2-Propenamide, N-[3-[3-[(2-chloro-6-fluorophenyl)methyl]-1,2,3,4,7,8-hexahydro-1-methyl-2,4-dioxopyrimido[2,1-f]purin-9(6H)-yl]phenyl]-

2-Propenamide, N-[3-[3-[(2-chloro-6-fluorophenyl)methyl]-1,2,3,4,7,8-hexahydro-1-methyl-2,4-dioxopyrimido[2,1-f]purin-9(6H)-yl]phenyl]- Struktur
2752352-90-0
CAS-Nr.
2752352-90-0
Englisch Name:
2-Propenamide, N-[3-[3-[(2-chloro-6-fluorophenyl)methyl]-1,2,3,4,7,8-hexahydro-1-methyl-2,4-dioxopyrimido[2,1-f]purin-9(6H)-yl]phenyl]-
Synonyma:
KRAS G12C inhibitor 30;2-Propenamide, N-[3-[3-[(2-chloro-6-fluorophenyl)methyl]-1,2,3,4,7,8-hexahydro-1-methyl-2,4-dioxopyrimido[2,1-f]purin-9(6H)-yl]phenyl]-
CBNumber:
CB212237203
Summenformel:
C25H22ClFN6O3
Molgewicht:
508.93
MOL-Datei:
2752352-90-0.mol

2-Propenamide, N-[3-[3-[(2-chloro-6-fluorophenyl)methyl]-1,2,3,4,7,8-hexahydro-1-methyl-2,4-dioxopyrimido[2,1-f]purin-9(6H)-yl]phenyl]- Eigenschaften

Dichte
1.46±0.1 g/cm3(Predicted)
pka
13.51±0.70(Predicted)

Sicherheit

2-Propenamide, N-[3-[3-[(2-chloro-6-fluorophenyl)methyl]-1,2,3,4,7,8-hexahydro-1-methyl-2,4-dioxopyrimido[2,1-f]purin-9(6H)-yl]phenyl]- Chemische Eigenschaften,Einsatz,Produktion Methoden

2-Propenamide, N-[3-[3-[(2-chloro-6-fluorophenyl)methyl]-1,2,3,4,7,8-hexahydro-1-methyl-2,4-dioxopyrimido[2,1-f]purin-9(6H)-yl]phenyl]- Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


2-Propenamide, N-[3-[3-[(2-chloro-6-fluorophenyl)methyl]-1,2,3,4,7,8-hexahydro-1-methyl-2,4-dioxopyrimido[2,1-f]purin-9(6H)-yl]phenyl]- Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 2)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Nantong Hanfang Biotechnology Co. , Ltd. 18616537568
hanfangpharma@126.com China 30968 58
TargetMol Chemicals Inc. 15002134094
marketing@targetmol.cn China 19696 58

  • 2-Propenamide, N-[3-[3-[(2-chloro-6-fluorophenyl)methyl]-1,2,3,4,7,8-hexahydro-1-methyl-2,4-dioxopyrimido[2,1-f]purin-9(6H)-yl]phenyl]-
  • KRAS G12C inhibitor 30
  • 2752352-90-0
  • C25H22ClFN6O3
Copyright 2019 © ChemicalBook. All rights reserved